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Previously, we demonstrated that cytochrome P450 2B1
(CYP2B1) can generate reactive oxygen species in puromycin
aminonucleoside (PAN)-induced nephrotic syndrome, an
animal model of minimal-change disease in humans. In this
study we found that overexpression of CYP2B1 in rat
glomerular epithelial cells in vitro significantly increased
PAN-induced reactive oxygen species generation,
cytotoxicity, cell death, and collapse of the actin
cytoskeleton. All of these pathological changes were
markedly attenuated by siRNA-induced CYP2B1 silencing.
The cellular CYP2B1 protein content was significantly
decreased whereas its mRNA level was markedly increased,
suggesting regulation by protein degradation rather than
transcriptional inhibition in the PAN-treated glomerular
epithelial cells. This degradation of CYP2B1 was accompanied
by the induction of heme oxygenase-1, an important
indicator of heme-induced oxidative stress. In PAN-treated
CYP2B1-silenced glomerular epithelial cells the induction of
heme oxygenase-1 and caspase-3 activity were significantly
decreased. Further, cleavage of the stress-induced pro-
apoptotic endoplasmic reticulum-specific pro-caspase-12 was
prevented in the silenced cells. Our results support a pivotal
role of CYP2B1 for reactive oxygen species production in
the endoplasmic reticulum in PAN-induced cytotoxicity.
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Reactive oxygen species (ROS) are important mediators of
puromycin aminonucleoside (PAN)-induced experimental
nephrotic syndrome, which mimics minimal-change disease
in humans.1,2 The precise site and source responsible for
generation of ROS are currently not well established. The
cytochrome-P450 (CYP) superfamily is a group of heme
protein that act primarily as monooxygenases in the synthesis
and metabolism of many endogenous and xenobiotic
compounds.3 However CYP can also function as oxidases
and generate superoxide and hydrogen peroxide (H2O2)
during the uncoupled oxidation of NADPH.4–6 These ROS
may cause breakdown of the CYP heme protein with the
release of catalytic iron, which in turn generates more potent
tissue-damaging oxidants such as hydroxyl radical (OH  ).
The importance of CYP enzymes in the pathological
processes of the kidney has become apparent during the
past few years.7–10 However the role of CYP as a site for ROS
generation and a source of iron has not been fully explored.
Moreover, the contribution of individual CYP enzymes to
ROS generation leading to oxidative stress is only partially
elucidated.11–13 In our recent studies we have identified and
localized CYP2B1 to the rat glomeruli and to glomerular
epithelial cells (GECs) by western blotting and immuno-
histochemical analysis.14,15 Generic CYP inhibitors markedly
attenuated the PAN-induced proteinuria and cytotoxicity to
the GECs.14,15 The podocytes or GECs are highly specialized
cells and injury to these cells leads to the initiation and
progression of nephrotic syndrome.16,17 The major structural
change in PAN-induced nephrotic syndrome is fusion of the
foot processes of the GECs and focal detachment from
the glomerular basement membrane.18 The precise molecular
mechanisms leading to this injury and proteinuria are poorly
understood, although ROS have been implicated. We postu-
late that PAN, by interacting with CYP2B1 in the GECs,
increases the formation of H2O2, which causes breakdown of
the heme protein with the release of catalytic iron and heme.
Catalytic iron promotes the generation of OH  and other
powerful oxidants causing injury. The released heme causes
induction of heme oxygenase-1 (HO-1), which is protec-
tive.19 This study was designed to increase the specificity of
our previous observations by ectopic expression of the
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CYP2B1 gene through adenovirus-mediated gene transfer
and by knockdown of CYP2B1 using short interfering RNA
(siRNA) technology.
RESULTS
Overexpression/silencing of CYP2B1 in cultured GECs
We have previously identified and localized CYP2B1 to the
GECs by immunocytochemistry and western blot analysis.14
In this study, expression of CYP2B1 mRNA in cultured GECs
was determined by real-time reverse transcriptase-PCR
(RT-PCR). Both real-time RT-PCR and western blot analysis
indicated that CYP2B1 has relatively low basal expression in
the rat GECs. Hence all our current experiments were
performed using GECs infected for 24 h with an adenoviral
vector that expresses rat CYP2B1 cDNA. Both real-time
RT-PCR and western blot analysis confirmed the expression
of CYP2B1 (Figure 1a–c). A CYP2B1 siRNA mixture
decreased both CYP2B1 mRNA and protein in GECs by
B65% after 48 h of transfection (Figure 2a–c).
Overexpression of CYP2B1 exacerbates whereas silencing of
CYP2B1 attenuates PAN-induced H2O2 and OH . generation,
cytotoxicity, and cell death
GECs infected with CYP2B1 virus showed significant increase
of H2O2 generation before PAN treatment (Figure 3a).
Incubation of GECs overexpressing CYP2B1 with PAN
(2.5 mM) resulted in a marked increase in H2O2 generation
in a time-dependent manner (Figure 3b), with significant
production of OH  (Figure 4). The increased in ROS was
accompanied by a significant increase in PAN-induced cyto-
toxicity and cell death as measured by LDH release and
Trypan blue exclusion (Figure 5). Infection with an empty
adenovirus did not significantly change PAN-mediated H2O2
production, LDH release, or cell survival as compared with
that in control cells incubated with PAN (Figures 3b and 5)
suggesting that the changes caused by CYP2B1 overexpres-
sion are CYP2B1-gene-specific. Moreover, CYP2B1 silencing
prevented the marked increase in PAN-mediated H2O2 gene-
ration (Figure 6), reduced OH  formation (Figure 4),
and significantly attenuated cytotoxicity and cell death
(Figure 7a). Calcein AM/ethidium-1 fluorescent staining60
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Figure 1 |Upregulation of CYP2B1 mRNA and protein by
adenovirus in GECs. (a) CYP2B1 mRNA levels were detected
by real-time RT-PCR in glomerular epithelial cells (GECs) 24 h after
infection with a CYP2B1 adenovirus (adv) as described under
Methods. (b) The protein levels of CYP2B1 were determined by
western blotting in GECs 24 h after infection with a CYP2B1
adenovirus (adv). The blots are representative of three independent
experiments. (c) Densitometric analysis of the blots is shown. The
values are the mean±s.e.; *Po0.05, compared with untreated or
control (con) GECs.
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Figure 2 | siRNA-mediated knockdown of CYP2B1 mRNA and
protein in the GECs. (a) CYP2B1 mRNA levels were detected
in GECs that overexpress the CYP2B1 gene (adv) and transiently
transfected with the CYP2B1 siRNA mixture for 48 h by real-time
RT-PCR. (b) The protein levels of CYP2B1 were determined by
western blotting in the GECs treated as described in panel a.
The blots shown are representative of three independent
experiments. (c) Densitometric analysis of the blots is shown.
The values are the mean±s.e.; *Po0.05 compared with adv.
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confirmed the above results. In untreated cells the percentage
of dead cells (red fluorescence) was o1%. Treatment with
PAN increased the number of dead cells to 28%. Transfection
of cells with scrambled (negative) siRNA did not significantly
change PAN-induced cell death (23%) whereas CYP2B1siR-
NA decreased it to 13% (Figure 7b).
PAN-mediated loss of CYP2B1 is a post-translational event
Breakdown of CYP2B1 protein is crucial for release of
catalytic iron and formation of OH  resulting in injury.
CYP2B1 protein level was significantly decreased 1 h after
treating cultured GECs with PAN. By contrast, CYP2B1
mRNA levels measured at the same time were increased
rather than decreased after PAN treatment (Figure 8a and b).
The increase in CYP2B1 mRNA may be due to compensation
of the loss of CYP2B1 protein. These results suggest post-
translational rather than transcriptional effects of PAN on the
loss of CYP2B1 protein.
Induction of HO-1 by PAN
We postulate that breakdown of the CYP2B1 heme protein by
ROS results in the release of heme, which causes induction of
the HO-1, an additional feature of oxidative stress. There was
1000
800
600
400
200
0
800
700
500
600
400
300
200
100
30 60 90 120 150
(Time min)
adv+PAN
–adv+PAN
con+PAN
adv
–adv
con *
con –adv adv
*
*
*
*
D
CF
 fl
uo
re
sc
en
ce
D
CF
 fl
uo
re
sc
en
ce
Figure 3 |Generation of H2O2 in GECs that overexpress the
CYP2B1 gene in the basal state and after addition of PAN.
(a) Generation of H2O2 was determined in GECs infected with
the CYP2B1-expressing adenovirus (adv) or an empty adenovirus
(–adv) and control (con) cells in the basal state before addition of
PAN. (b) Generation of H2O2 was measured in GECs infected with
the CYP2B1-expressing adenovirus (adv) or an empty adenovirus
(–adv) and control (con) cells between 30 and 150min after
treatment with or without 2.5mM PAN using the oxidant-sensitive
fluorescent dye DCFH-DA. The data at each time point represent
net H2O2 production (PAN-induced minus respective control) and
are the mean±s.e. (n¼ 3); *Po0.05, compared with con cells
treated with PAN. PAN, puromycin aminonucleoside.
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Figure 4 | Effect of CYP2B1 siRNA on hydroxyl radical
formation in GECs treated with PAN. The CYP2B1 gene was
silenced (siRNA) in GECs infected with the CYP2B1-expressing
adenovirus (adv) and treated with or without 2.5mM PAN.
Generation of hydroxyl radical was determined at 150min after
treatment with PAN. To show the specificity of CYP2B1 siRNA,
a negative siRNA (ve siRNA) group was included. The values
are the mean±s.e. (n¼ 3); *Po0.05, compared with adv cells;
þPo0.05, compared with siRNAþ PAN.
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Figure 5 | Effect of overexpression of CYP2B1 on cytotoxicity
and cell death in the GECs. Cytotoxicity (LDH release) and cell
viability (Trypan blue exclusion) were determined in the control
(con) cells and in GECs infected with a CYP2B1-expressing
adenovirus (adv) or a negative adenovirus (adv) after 48 h of
treatment with or without 2.5mM PAN. The data represent the
percentage of increase compared with the respective untreated
control. The values are the mean±s.e. (n¼ 3); *Po0.05, compared
with conþ PAN.
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marked upregulation of HO-1 in the PAN-treated GECs, as
indicated by western blotting. GECs transfected with CYP2B1
siRNA and treated with PAN showed significant decrease in
HO-1 induction (Figure 9).
ER-associated caspase-12 activation
Caspase-12 is an endoplastic reticulum (ER)-specific caspase
that has a crucial role in the ER stress-induced apoptotic
pathway.20 CYP2B1 is an ER-resident heme protein. Hence
it was important to determine whether the oxidative stress
resulting from the breakdown of CYP2B1 resulted in acti-
vation of the ER-specific caspase-12. In this study, pro-
caspase-12 was significantly decreased in GECs treated with
PAN for 48 h, whereas the active form of caspase-12 was
increased. Cleavage of pro-caspase-12 was prevented in GECs
transfected with CYP2B1 siRNA (Figure 10a). Similarly,
caspase-3 activity was markedly increased in GECs treated
with PAN and this was significantly attenuated in the
CYP2B1 siRNA-transfected cells (Figure 10b).
Effect of CYP2B1 gene silencing on PAN-induced
reorganization of actin filament
The actin cytoskeletal structure has an important role in
maintaining the architecture of the podocyte foot processes.21
We therefore examined the effect of CYP2B1 gene silencing
on the morphological changes of GECs treated with PAN.
Before PAN treatment, F-actin staining showed a character-
istic spindle-like appearance of the GECs with numerous cell
processes and prominent actin stress fibers. Treatment of the
GECs with PAN resulted in retraction of the processes with
disruption of the actin filaments (Figure 11). CYP2B1 gene
silencing protected the cells from PAN-induced actin
reorganization, whereas scrambled siRNA did not show any
protective effects. These results suggest that PAN-induced
disruption of the actin cytoskeleton is mediated through
CYP2B1.
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Figure 6 | Effect of CYP2B1 siRNA on PAN-induced generation
of H2O2 in the GECs. CYP2B1 gene was silenced in GECs infected
with a CYP2B1 adenovirus (adv) and treated with or without
2.5mM PAN. Intracellular generation of H2O2 was measured using
the oxidant-sensitive fluorescent dye DCFH-DA 30–120min after
treatment with PAN. A negative siRNA group was included to
increase the specificity of our observation. The data at each time
point represent net H2O2 production (PAN-induced minus
respective endogenous control). The values are the mean±s.e.
(n¼ 3); *Po0.05, compared with advþ PAN.
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Figure 7 | Effect of CYP2B1 siRNA on PAN-induced cytotoxicity
and cell death in the GECs. (a) GECs were infected with a
CYP2B1-expressing adenovirus (adv) and treated with or without
2.5mM PAN. LDH release and Trypan blue exclusion were
determined 48 h after treatment in GECs that were non-
transfected and transiently transfected with CYP2B1 siRNA or
negative siRNA, and expressed as percentage of untreated
controls. The values are the mean±s.e. (n¼ 3); *Po0.05,
compared with advþ PAN. (b) Presence of live (green
fluorescence) and dead (red fluorescence) cells were determined
in GECs infected with a CYP2B1-expressing adenovirus (adv) 48 h
after treatment with or without 2.5mM PAN in the presence of
CYP2B1 siRNA or negative siRNA as described under Methods.
The picture shown is representative of three independent
experiments.
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DISCUSSION
CYP enzymes are not only crucial in the elimination of
foreign compounds but also have a pivotal role in the
generation of ROS that are associated with cell damage.22 We
have identified and localized CYP2B1 to rat GECs. CYP2B1 is
expressed at a very low basal level in primary hepatocytes23
and in GECs, as shown by real-time RT-PCR and western
blot analysis. In cultured rat hepatocytes, phenobarbital (PB)
induction of CYP2B1 is most pronounced.24,25 However, we
have not been able to show increased induction of CYP2B1 in
PB-treated kidney glomeruli and GECs (data not shown),
consistent with the observations of Guengerich et al.13,26
Hence our experiments in this study were performed using
GECs infected with an adenoviral vector that encodes the rat
CYP2B1 cDNA.
ROS have an important role in the alteration of the GEC
morphology leading to proteinuria.27,28 Using CYP inhibitors
we have shown marked reduction in ROS generation with
attenuation of proteinuria in a PAN model of nephrotic
syndrome and PAN-induced GEC cytotoxicity.14,15 This
study extends those findings by gene-specific targeting of
CYP2B1. Both in vivo and in vitro studies have shown that
CYP2B1 induction by PB treatment was selectively associated
with oxidative stress.29,30 Recent studies indicated that the
ability of PB to selectively induce in vivo oxidative stress was
related to decreases in glutathione peroxidase and pyridine
nucleotides, which normally protect cells from ROS.13,26 In
this study, ROS generation in GECs overexpressing CYP2B1
was significantly higher than that in control cells even in the
basal state (Figure 3a). Moreover, exposure of these CYP2B1-
overexpressing cells to PAN markedly increased ROS gene-
ration and significantly increased cytotoxicity. These results
suggest that the changes resulting from CYP2B1 over-
expression are gene-specific (Figures 3a, b and 5). Silencing
of CYP2B1 attenuated PAN-induced ROS generation and
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Figure 8 | Effect of PAN treatment on mRNA and protein levels
of CYP2B1 in the GECs. (a) The protein levels of CYP2B1 were
determined by western blotting in CYP2B1-overexpressing GECs
(adv) after incubation with or without 2.5mM PAN for 1 h. The
blots shown are representative of three independent
experiments. (b) Similarly, CYP2B1 mRNA levels were detected by
real-time RT-PCR in GECs overexpressing the CYP2B1 gene 1 h
after incubation with or without 2.5mM PAN. The values are±s.e.
(n¼ 3); *Po0.05, compared with adv.
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Figure 9 | Effect of CYP2B1 gene knockdown on HO-1 level
after treatment with PAN. The level of HO-1 protein was
determined by western blotting in the CYP2B1-overexpressing
GECs (adv) after 48 h of treatment with or without 2.5mM PAN in
the presence of CYP2B1 siRNA or negative siRNA. The blots shown
are representative of three independent experiments.
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Figure 10 | Effect of PAN treatment on caspase-12 cleavage
and caspase-3 activity in the GECs. (a) Pro-caspase and cleaved
caspase-12 were determined by western blotting in the CYP2B1-
overexpressing GECs (adv) 48 h after treatment with or without
2.5mM PAN in the presence of CYP2B1 siRNA or negative siRNA.
The blots shown are representative of three independent
experiments. (b) Caspase-3 activity was measured in the GECs
treated as described in panel a 48 h after incubation with or
without 2.5mM PAN in the presence of CYP2B1 siRNA or negative
siRNA as described under Methods. The values represent arbitrary
units of luminescence and are the mean±s.e.; *Po0.001,
compared with adv; þPo0.001, compared with þ PAN.
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cytotoxicity. Therefore, CYP2B1 is indeed the source of
generation of intracellular H2O2 leading to oxidant injury.
The heme moiety of the CYP may serve as an important
source of catalytic iron capable of catalyzing free-radical
reactions.9,31–34 CYP inactivation in PAN-treated cells may
involve the formation of active oxygen species accompanied
by bleaching of the heme protein as a result of heme loss
or degradation.35 The CYP would then be inactivated
and catabolized with release of heme and catalytic iron,
which promotes the generation of OH  and induces lipid
peroxidation. In this study the marked increase in OH 
generation in PAN-treated GECs was significantly decreased
upon silencing of CYP2B1 (Figure 4), confirming the role of
CYP2B1 in the generation of the OH  and subsequent injury.
The induction of CYP2B1 mRNA by PB can be modulated
in a redox-sensitive manner.22 Redox regulation of CYP2B1
mRNA in GECs is also suggested in this study, where CYP2B1
mRNA levels were increased four-fold within 1 h of PAN
treatment, at which time CYP2B1 protein was significantly
decreased (Figure 8). This increase in CYP2B1 mRNA may be
a compensatory effect to replace the CYP2B1 protein.
Furthermore, these results indicate a post-translational rather
than a post-transcriptional effect of PAN on the loss of
CYP2B1 protein.
Agents that promote the induction of the heme-degrading
enzyme HO-1 cause a release of the heme from CYP, which in
turn leads to activation of HO-1.36 HO-1 was induced in
PAN-treated glomeruli and GECs after marked generation of
H2O2 and degradation of CYP2B1, which was attenuated by
CYP inhibitors.14,15 In our current study, HO-1 induction
was markedly increased in PAN-treated GECs, with signi-
ficant decrease in the CYP2B1-silenced cells (Figure 9). Thus,
breakdown of the CYP2B1 heme protein leads to release of
heme, which in turn induces HO-1. A similar protective
effect was observed after stabilization of CYP by carbon
monoxide, thus preventing its degradation, induction of
HO-1, and oxidative stress.10
Caspases are cysteine proteases that have an important
role in programmed cell death.37,38 Fogo et al. have shown
marked increase in the active form of caspase-3 in PAN-
induced apoptosis.39 Caspase-3 activity was markedly
increased after PAN treatment but was significantly decreased
in the CYP2B1-silenced cells (Figure 10b). Caspase-12 is an
ER-specific caspase that participates in apoptosis under ER
stress.20,40,41 It is an initiator caspase that undergoes
activation in response to apoptotic stimuli and in turn
activates downstream effector caspases that are responsible
for the cleavage of a wide variety of physiological substrates.42
The PAN-induced increase in the active form of caspase-12
was significantly ameliorated in the GECs transfected with
CYP2B1 siRNA (Figure 10a). Caspase-12 and caspase-3
could be functioning in conjunction with each other or
independently.
The actin cytoskeleton is a major constituent of the
glomerular foot processes and reorganization of the actin
filaments leads to effacement of the foot processes.17 There is
increasing evidence to indicate that PAN induces actin
cytoskeletal depolarization that can result in structural
changes of the podocyte and leakage of the protein through
the slit diaphragm.43–46 CYP inhibitors enhance the pre-
servation of the individual foot processes of the podocytes
and protect from PAN-induced proteinuria.15 In this study
CYP2B1 gene silencing prevented the disruption of the actin
cytoskeleton induced by PAN (Figure 11), confirming that
disorganization of the actin cytoskeleton is mediated by
CYP2B1-induced oxidative stress in an in vitro model of
PAN-induced cytotoxicity.
Experimental animal models are commonly used to
predict the mechanism of podocyte injury in humans despite
species variability.47 The majority of the rat strains are prone
to PAN-induced injury with effacement of foot processes
and development of proteinuria, whereas most of the mice
strains have been traditionally resistant.48,49 Differences in
the genetic traits, including prior presence of hypercholes-
terolemia, have been associated to the development of
PAN-induced proteinuria.50–52 Harris et al. have shown that
PAN induces reversible proteinuric injury in transgenic mice
expressing cyclooxygenase-2 in the podocytes.53 Expression
of cyclooxygenase-2 in the vascular endothelial cells has been
linked to the CYP.54 Prostanoids have also been shown to
downregulate PB-induced CYP 2B1 gene expression.55 There
are marked specific inter- and intra-tissue differences in the
expression and inducibility of the CYP in the different strains
adv +PAN
siRNA+PAN–ve siRNA+PAN
Figure 11 | Effect of CYP2B1 gene silencing on PAN-induced
reorganization of the actin cytoskeleton. CYP2B1-overexpressing
GECs (adv) were treated with or without 2.5mM PAN for 48 h in
the presence of CYP2B1 siRNA or negative siRNA. Cells were fixed,
permeabilized, and hybridized with Alexa-Fluor-488-conjugated
phalloidin as described under Methods. The pictures are
representative of three independent experiments.
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and species.56 This may determine the generation of H2O2,
breakdown of the heme protein, release of catalytic iron, and
the formation of the hydroxyl radical leading to disruption of
the cytoskeleton and proteinuria on the basis of the
interaction between PAN and CYP2B1. We have not been
able to show expression of the CYP2B1 in the 129/SV strain
of mice glomeruli both by immunohistochemistry and
western blot analysis (unpublished data). Transgenic mice
with expression of CYP2B1 in the podocyte may provide
better understanding of the pathogenesis of PAN-induced
nephrotic syndrome. Autophagy represents an important
protective mechanism that attempts to rescue cells from
apoptosis.57,58 In a recent communication Huber et al.
observed a significant level of autophagy in the podocytes in
mice under pathophysiological conditions and this loss of
autophagy resulted in increased susceptibility to injury in
models of glomerular disease (Renal Week 2009, San Diego,
CA, F-FC 275).
In conclusion, using CYP2B1-gene-specific silencing we
have confirmed that CYP2B1 has a crucial role as the primary
site for generation of ROS. Furthermore, we have shown that
PAN acts at the level of CYP2B1 protein to increase the
production of ROS and induce degradation of CYP2B1
protein with release of heme and iron. The free iron
participates in OH  generation whereas the heme causes
induction of HO-1. The resultant cytotoxicity and cell
death is mediated through an ER stress-associated apop-
totic pathway. These findings may facilitate the identification
of specific CYP forms in human kidney that exert func-
tions similar to CYP2B1 and thus offer a valuable thera-
peutic target in the treatment of minimal-change disease in
humans.
MATERIALS AND METHODS
Cell culture
Rat GECs (kindly provided by Dr S Kasinath, University of Texas
Health Science Center) were maintained in Dulbecco’s modified
Eagles medium/F12 (1:1) medium supplemented with 10% fetal
bovine serum, 100 U/ml insulin, and 5% penicillin/streptomycin in
a humidified atmosphere of 5% CO2–95% air at 37 1C and fed at
intervals of 3 days as described.14
Adenoviral infection
GECs grown in six-well plates were incubated for 3 h at 37 1C in full
medium containing 1 108 IFU/ml of an adenovirus vector that
contains the rat CYP2B1 gene.59 The cells were then washed with
culture medium and further incubated in full medium for 24 h
at 37 1C. Empty adenovirus (AdNull; Vector Biolabs, Philadelphia,
PA, USA) was used as negative control.
CYP2B1 gene silencing
The experiments were performed in six-well plates in triplicate when
cells reached 60–70% confluence, according to the manufacturer’s
recommendation (Dharmacon, Chicago, IL, USA). In brief, transfection
reagent (DharmaFECT no. 1; 6ml per well) and rat CYP2B1 siRNA
(ON-TARGET plus SMART pool L-081876-01–0010) solution (20 nM)
were prepared. These two components were mixed and added to an
antibiotic-free complete medium and the cells were incubated for
48 h under 5% CO2–95% air at 37 1C. The extent of knockdown was
determined by real-time RT-PCR and western blotting.
Measurement of intracellular H2O2 generation in the GECs
Intracellular generation of H2O2 in the GECs was assayed using the
oxidant-sensitive fluorescent dye dichlorodihydrofluorescein diacetate
(DCFDA).60 In brief, confluent GECs were cultured in the presence or
absence of adenovirus, harvested by trypsinization, and suspended in
Dulbecco’s Phosphate Buffered Saline buffer. Cell suspensions were then
transferred to a microplate (2–5 105 cells/well) and incubated at room
temperature with DCFDA (10mg/ml) with or without PAN (2.5 mM) for
30 min. At the end of the incubation period, the fluorescence intensity
of the cell suspension was read up to 150 min using a fluorescence plate
reader (excitation at 485 nm, emission at 535 nm).
Measurement of OH . production
2-Deoxy-D-ribose at a final concentration of 3 mM was added to the
medium just before incubation with or without PAN (2.5 mM). At
the end of 150 min of incubation, the incubation medium was
collected for measurement of OH  formation by the deoxyribose
degradation method.61
Measurement of cytotoxicity
Cytotoxicity was assessed using the ‘CytoTox-One Homogenous
Membrane Integrity’ assay kit (Promega, Madison, WI, USA). After
48 h of treatment with or without 2.5 mM PAN an aliquot of the
growth medium was removed and stored. The monolayer was lysed
according to the manufacturer’s recommendation and LDH content
was determined using a colorimetric substrate both in the medium
and the cell lysate. LDH release was calculated as a percentage of
LDH content in the medium as compared with the total LDH
content (mediumþ lysate).62
Cell viability/survival
Viable cell count was determined by Trypan blue (Sigma, St Louis,
MO, USA) exclusion using a hemocytometer. To determine the
extent of cell viability, the ‘LIVE/DEAD Viability/Cytotoxicity Assay
kit’ (Invitrogen, Carlsbad, CA, USA) was used as suggested by the
manufacturer. The kit contains two fluorescent dyes: calcein AM,
which is retained by live cells and emits green fluorescence, and
ethidium-1, which is taken up by damaged cells but excluded by live
cells: it emits red fluorescence. Briefly, cells grown in six-well plates
were treated with or without 2.5 mM PAN for 48 h in the presence
or absence of either a scrambled siRNA or a CYP2B1 siRNA.
Monolayers were washed with phosphate-buffered saline and stained
with calcein AM and ethidium-1 for 20 min. After repeated washing
with phosphate-buffered saline, red and green fluorescence was
observed using a Nikon Eclipse TS100F inverted fluorescent
microscope at  100 magnification. The percentage of dead cells
was determined by counting dead (red) and live (green) cells.
Western blotting
Monolayers of GECs were lysed in a radio-immunoprecipitation
buffer that contained a Protease inhibitor cocktail (Sigma-Aldrich,
St Louis, MO, USA). Protein content was determined by using a
Bio-Rad Protein Determination assay kit (Bio-Rad, Hercules,
CA, USA) as described earlier.63 In brief, 100 mg of cell lysate
protein were separated bysodium dodecyl sulfate–polyacrylamide gel
electrophoresis and transferred to a polyvinylidene difluoride
membrane (Bio-Rad, Hercules, CA, USA). The filters were
hybridized with the appropriate primary antibodies followed by a
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horseradish peroxidase-conjugated secondary antibody. The bands
were visualized by an enhanced chemiluminescence method (Pierce,
Rockford, IL, USA) and quantified by densitometry (UnScan-It Gel
v6.1; Silk Scientific, Orem, UT, USA.). Polyclonal goat anti-rat
CYP2B1 antibody was obtained from Millipore, Temecula, CA, USA.
Polyclonal anti-rat caspase-12 and anti-rat-horseradish peroxidase
antibodies were purchased from Sigma-Aldrich (St Louis, MO, USA).
Anti-mouse actin antibody was purchased from Millipore. Anti-goat
horseradish peroxidase-conjugated secondary antibody was purchased
from Cell Signaling Technology (Santa Cruz, CA, USA.).
Determination of caspase-3/7 activity
Caspase-3/7 activity was determined using the ‘Caspase-Glo 3/7 Assay’
kit (Promega) as recommended by the manufacturer. Briefly, GEC
monolayers were treated with or without 2.5 mM PAN in the presence
or absence of either a scrambled siRNA or a CYP2B1 siRNA. After
48 h the Caspase-Glo 3/7 reagent was added and incubated at room
temperature for 30 min. Luminescence was determined using a
Modulus Luminometer (Turner BioSystem, Sunnyvale, CA, USA).
Real-time RT-PCR
Real-time RT-PCR assays were performed using the iQ SYBR Green
Supermix (Bio-Rad Laboratories) using an iCycler iQ Real-Time
PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA).
The CYP2B1 primer was designed using the sequence obtained from
rat CYP2B1 (GenBank accession no. J00719). Forward sequence:
50-CGCATGGAGAAGGAGAAGTC-30 and reverse sequence: 50-GCC
GATCACCTGATCAATCT-30. Relative fold change in mRNA level was
quantified by the 2–Ct mathematical model.
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Immunofluorescence
GECs grown on cover-glass were transiently transfected with
scrambled or CYP2B1-specific siRNAs as described above. After
48 h the medium was replaced with fresh medium that contained
2.5 mM PAN. After 48 h of PAN treatment the cells were washed with
phosphate-buffered saline and fixed in 4% paraformaldehyde for
10 min at room temperature followed by permeabilization with
0.1% Triton X-100 for 5 min at room temperature. The cells were
washed, labeled with Alexa-Fluor-488 phalloidin (Invitrogen), and
counterstained with 40,6-diamidino-2-phenylindole (Invitrogen) as
recommended by the manufacturer. Fluorescence was observed
using a Nikon Eclipse TS100F inverted microscope equipped with
a fluorescein isothiocyanate and CY3 filter at  400 magnification.
Images were captured using a Nikon DS cooled camera and analyzed
using the NIS Elements Basic Research 3.0 software.
Statistical analysis
Continuous variables were expressed as mean and standard
deviation (s.d.). Means of multiple treatment groups were compared
with that of the controls by using Student’s t-test. A P-value o0.05
was considered statistically significant. All analyses were performed
using the SigmaStat 3.5 software package.
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